• 1
    Hoek HW, van Hoeken D. Review of the prevalence and incidence of eating disorders. Int J Eat Disord 2003; 34: 383396.
  • 2
    Sullivan PF. Mortality in anorexia nervosa. Am J Psychiatry 1995; 152: 1073,1074.
  • 3
    Theander S. Anorexia nervosa. A psychiatric investigation of 94 female patients. Acta Psychiatr Scand Suppl 1970; 214: 1194.
  • 4
    Crow SJ, Peterson CB. The economic and social burden of eating disorders: A review in eating disorders. In: MajM, HalmiK, Lopez-IburJJ, SartoriusN, editors. Eating Disorders. West Sussex, England: Wiley, 2003, pp. 383396.
  • 5
    Powers PS, Bannon Y. Medical comorbidity of anorexia nervosa, bulimia nervosa, and binge eating disorder. In: BrewertonT, editor. Clinical Handbook of Eating Disorders: An Integrated Approach. New York: Marcel Dekker, 2004, pp. 231255.
  • 6
    Striegel-Moore RH, Leslie D, Petrill SA, Garvin V, Rosenheck RA. One-year use and cost of inpatient and outpatient services among female and male patients with an eating disorder: Evidence from a national database of health insurance claims. Int J Eat Disord 2000; 27: 381389.
  • 7
    Jones E, Watson JP. Delusion, the over valued idea and religious beliefs: A comparative analysis of their characteristics. Br J Psychiatry 1997; 170: 381386.
  • 8
    Garfinkel P. Multimodal therapies for anorexia nervosa. In: SanWJ, editor. Treating Eating Disorders. Francisco: Jossey-Bass, 1996, pp. 313333.
  • 9
    Ohrmann P, Kersting A, Suslow T, Lalee-Mentzel J, Donges US, Fiebich M, et al. Proton magnetic resonance spectroscopy in anorexia nervosa: Correlations with cognition. Neuroreport 2004; 15: 549553.
  • 10
    Kerem NC, Katzman DK. Brain structure and function in adolescents with anorexia nervosa. Adolesc Med 2003; 14: 109118.
  • 11
    Lambe EK, Katzman DK, Mikulis DJ, Kennedy SH, Zipursky RB. Cerebral gray matter volume deficits after weight recovery from anorexia nervosa. Arch Gen Psychiatry 1997; 54: 537542.
  • 12
    Pederson KJ, Roerig JL, Mitchell JE. Towards the pharmacotherapy of eating disorders. Expert Opin Pharmacother 2003; 4: 16591678.
  • 13
    Malina A, Gaskill J, McConaha C, Frank GK, LaVia M, Scholar L, et al. Olanzapine treatment of anorexia nervosa: A retrospective study. Int J Eat Disord 2003; 33: 234237.
  • 14
    Boachie A, Goldfield GS, Spettigue W. Olanzapine use as an adjunctive treatment for hospitalized children with anorexia nervosa: Case reports. Int J Eat Disord 2003; 33: 98103.
  • 15
    Powers PS, Santana CA, Bannon YS. Olanzapine in the treatment of anorexia nervosa: An open label trial. Int J Eat Disord 2002; 32: 146154.
  • 16
    Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987; 13: 261276.
  • 17
    Lob S, Pickel J, Bidlingmaier M, Schaaf L, Backmund H, Gerlinghoff M, et al. Serum leptin monitoring in anorectic patients during refeeding therapy. Exp Clin Endocrinol Diabetes 2003; 111: 278282.
  • 18
    American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington DC: American Psychiatric Association, 1994.
  • 19
    Guy W. ECDEU Assessment manual for psychopharmacology publication, ADM76-338. US Department of Health, Education, and Welfare, Rockville, MD, 1976.
  • 20
    Barnes TR. A rating scale for drug-induced akathisia. Br J Psychiatry 1989; 154: 672676.
  • 21
    Simpson GM, Angus JW. A rating scale for extrapyramidal side effects. Acta Psychiatr Scand Suppl 1970; 212: 1119.
  • 22
    Sheehan DV, Lecrubier Y. Multi International Neuropsychiatric Interview (M.I.N.I). Tampa, Florida Patent Screen 5.0.0/English Version/DSM-IV/7/1/02 2005 ( 2005).
  • 23
    Kay SR, Opler LA, Fiszbein A. PANSS: Positive and Negative Syndrome Scale Manual. North Tonawanda, NY: Multi-Health Systems, 2000.
  • 24
    Garner DM. The eating disorder inventory-2 (EDI-2). In: SedererL, DickeyB, editors. Outcome Assessment in Clinical Practice. New York, NY: William and Wilkins, 1997.
  • 25
    Mazure CM, Halmi KA, Sunday SR, Romano SJ, Einhorn AM. The Yale-Brown-Cornell eating disorder scale: Development, use, reliability and validity. J Psychiatr Res 1994; 28: 425445.
  • 26
    Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 5662.
  • 27
    Spielberger C. State-Trait Anxiety Inventory (Form Y). Palo Alton, CA: Mind Garden, 1983.
  • 28
    Mitchell JE, Tareen B, Sheehan W, Agras S, Brewerton TD, Crow S, et al. Establishing guidelines for pharmacotherapy trials in bulimia nervosa and anorexia nervosa. Int J Eat Disord 2000; 28: 17.
  • 29
    Lambert M, Haro JM, Novick D, Edgell ET, Kennedy L, Ratcliff M, et al. Olanzapine vs. other antipsyhotics in actual outpatient settings: Six months tolerability results from the European Schizophrenia Out-patient Health Outcomes study. Acta Psychiatr Scand 2005; 111: 232243.